- US12071468utility2024Purification of Factor VIII Subspecies0 cites
- US12065448utility2024Heteroaryl Plasma Kallikrein Inhibitors0 cites
- USD1039135design2024Infusion Pump0 cites
- US12060382utility2024Crystalline Phases of 5,6-dichloro-2-(isopropylamino)-(1 Β-l-ribofuranosyl)-1h-benzimidazole0 cites
- US12061206utility2024Diagnosis and Treatment of Autoimmune Diseases0 cites
- US12053526utility2024Methods for Treatment Using Anti-alpha4beta7 Antibody0 cites
- US12054474utility2024Sulfonyl Piperidine Derivatives and Their Use for Treating Prokineticin Mediated Diseases0 cites
- US12054512utility2024Sting Modulator Compounds, and Methods of Making and Using0 cites
- US12048699utility2024Cancer Treatment Methods Based on TP53 Mutation Status and Hypermutation0 cites
- US12031130utility2024Composition for Modifying Target Gene0 cites
- US12024505utility2024Heterocyclic Compounds Useful as Modulators of Acetylcholine Receptors0 cites
- US12024512utility2024Cocrystal0 cites
- US12018281utility2024Cardiomyocyte Maturation Promoter0 cites
- US12012419utility2024Heterocyclic Compound0 cites
- US12005054utility2024Piperidinyl-3-(aryloxy)propanamides and Propanoates0 cites
- US11999798utility2024Anti-factor IX Padua Antibodies0 cites
- US11993570utility2024Cationic Lipids0 cites
- US11987586utility2024Pyrrolo[1,2-c]imidazole Derivatives as Orexin Type 2 Receptor Agonists0 cites
- USRE049967reissue2024Combinations and Methods for Subcutaneous Administration of Immune Globulin and Hyaluronidase0 cites